Vascular Surgery / Drug-Eluting Therapies / Resources / Data Sheets     

 

 

Eluvia™ Drug-Eluting Vascular Stent System

1-year KM Chart primary patency estimate comparing Eluvia at 85.4% and BMS at 76.3%

EMINENT Clinical Trial Data Sheet

View the 1-year results from the world’s largest RCT of SFA stents: Eluvia DES vs. BMS.


Blue chart of KM Estimates Primary Patency rates Eluvia 92.1% and Zilver PTX 81.8%

IMPERIAL 1-Year Data Sheet

View the remarkable results Eluvia DES achieved in the first head-to-head trial: Eluvia DES vs. Zilver PTX.


Blue bar chart of IMPERIAL 2-year results for imperial.

IMPERIAL 2-Year Data Sheet

View 2-year results from the first head-to-head trial: Eluvia DES vs. Zilver PTX.


Chart of 12-month Primary Patency

Münster All-Comers Registry


Line chart of Freedom from TLR: Full Cohort 36 months

MAJESTIC 3-Year Follow-Up Data Sheet

See the unprecedented results of the MAJESTIC trial, which studied stenting of the superficial femoral and/or proximal popliteal artery with the Eluvia Drug-Eluting Stent.

Ranger™ Drug-Coated Balloon

Partial view of infographic displaying blue men

RANGER II SFA Pivotal Trial Data Sheet

See how Ranger DCB demonstrated exceptional outcomes at 2-years in the Ranger II SFA Pivotal Trial.


Partial line chart with results circled

COMPARE Clinical Data Sheet

Learn more about the world’s first head-to-head, prospective, multi-center Randomized Controlled Trial (1:1) comparing the lower dose Paclitaxel RANGER DCB (2 µg/mm2) to the higher dose Paclitaxel IN.PACT DCB (3.5 µg/mm2).

Background image of surgical area and healthcare providers' hands.

Explore DE Resources

Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.

Background image of healthcare providers' hands using medical equipment.

Stay Up to Date

Receive emails about the latest drug-eluting technology news, innovations and events in your area.

take the fight to pad
Top